Docosahexaenoic acid enhances the susceptibility of human colorectal cancer cells to 5-fluorouracil
β Scribed by Gabriella Calviello; Fiorella Di Nicuolo; Simona Serini; Elisabetta Piccioni; Alma Boninsegna; Nicola Maggiano; Franco O. Ranelletti; Paola Palozza
- Publisher
- Springer
- Year
- 2004
- Tongue
- English
- Weight
- 328 KB
- Volume
- 55
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract 5βFluorouracil (5βFU) is the major chemotherapeutic component for colorectal cancer (CRC) and other types of solid tumours. Resistance of cancer cells to 5βFU is considered the major obstacle for successful chemotherapy. NFβΞΊB is a transcription factor. Cancer cells with high NFβΞΊB nucl
## Abstract Our study was conducted to investigate whether anticancer drugs, cisplatin (CDDP) and/or 5βfluorouracil (5βFU), can modulate Fasβmediated apoptosis in oral squamous cell carcinoma (OSCC) cell lines. When OSCC cell lines, NA and HSCβ4, were treated with CDDP and/or 5βFU, Fas and its mRNA